BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8134579)

  • 1. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
    Evans AJ; Pinder S; Ellis IO; Sibbering M; Elston CW; Poller DN; Wilson R
    Radiology; 1994 Apr; 191(1):237-40. PubMed ID: 8134579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.
    Barreau B; de Mascarel I; Feuga C; MacGrogan G; Dilhuydy MH; Picot V; Dilhuydy JM; de Lara CT; Bussières E; Schreer I
    Eur J Radiol; 2005 Apr; 54(1):55-61. PubMed ID: 15797293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
    Evans A; Pinder S; Wilson R; Sibbering M; Poller D; Elston C; Ellis I
    AJR Am J Roentgenol; 1994 Jun; 162(6):1307-11. PubMed ID: 8191988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation.
    Gwak YJ; Kim HJ; Kwak JY; Lee SK; Shin KM; Lee HJ; Kim GC; Jang YJ; Han MH; Park JY; Jung JH
    Acta Radiol; 2011 May; 52(4):364-71. PubMed ID: 21498298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
    Carlson KL; Helvie MA; Roubidoux MA; Kleer CG; Oberman HA; Wilson TE; Pollak EW; Rochester AB
    AJR Am J Roentgenol; 1999 Feb; 172(2):313-7. PubMed ID: 9930774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ of the breast: mammographic-pathologic correlation.
    Poplack SP; Wells WA
    AJR Am J Roentgenol; 1998 Jun; 170(6):1543-9. PubMed ID: 9609171
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation.
    Stomper PC; Connolly JL; Meyer JE; Harris JR
    Radiology; 1989 Jul; 172(1):235-41. PubMed ID: 2544922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.
    Holland R; Hendriks JH
    Semin Diagn Pathol; 1994 Aug; 11(3):181-92. PubMed ID: 7831529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between mammographic manifestations and averaged histopathologic nuclear grade using prognosis-predict scoring system for the prognosis of ductal carcinoma in situ.
    Lee KS; Han BH; Chun YK; Kim HS; Kim EE
    Clin Imaging; 1999; 23(6):339-46. PubMed ID: 10899414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
    Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
    AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation.
    Hermann G; Keller RJ; Drossman S; Caravella BA; Tartter P; Panetta RA; Bleiweiss IJ
    Can Assoc Radiol J; 1999 Aug; 50(4):235-40. PubMed ID: 10459309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided quadrantectomy in patients with ductal carcinoma in situ detected preoperatively by mammographic calcifications.
    Sakakibara M; Yokomizo J; Shiina N; Kazama T; Nakamura R; Fujimoto H; Nagashima T; Takishima H; Nakatani Y; Miyazaki M
    J Am Coll Surg; 2014 Aug; 219(2):295-302. PubMed ID: 24880957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of surrogate endpoint biomarkers for ductal carcinoma in situ.
    Lagios MD
    J Cell Biochem Suppl; 1994; 19():186-8. PubMed ID: 7823590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
    Stomper PC; Geradts J; Edge SB; Levine EG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype.
    Stomper PC; Connolly JL
    AJR Am J Roentgenol; 1992 Sep; 159(3):483-5. PubMed ID: 1323923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ of the breast: Evaluation of main presentations on magnetic resonance imaging compared with findings on mammogram and histology.
    Badan GM; Roveda D; Paito S; Fleury Ede F; Maragno B; Campos MS; Ferreira CA; Ferreira FA
    Rev Assoc Med Bras (1992); 2016; 62(5):421-7. PubMed ID: 27656851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation.
    Georgian-Smith D; Lawton TJ
    AJR Am J Roentgenol; 2001 May; 176(5):1255-9. PubMed ID: 11312190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
    Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
    Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy in estimating tumor extension according to mammographic subtypes in patients with ductal carcinoma in situ.
    Sato M; Fukutomi T; Akashi-Tanaka S; Miyakawa K; Yamamoto N; Hasegawa T
    Jpn J Clin Oncol; 2002 May; 32(5):157-61. PubMed ID: 12110641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.